Interthyr Corporation

Marietta, OH 45750

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $2.75MM
First Award Date 08/01/05
Most Recent Award Date 09/01/10

Key Personnel

Last Name Name Awards Contact
Kohn Leonard D Kohn 3

3 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-135
Budget: 09/01/10 - 01/27/12

DESCRIPTION (provided by applicant): Interthyr Corporation (IC) is requesting an Advanced Technology Phase II STTR award to develop a novel agent with a new therapeutic paradigm: Inhibition of Toll-like receptor (TLR) expression and signaling in non-immune cells. In pursuing studies based on its Phase I award, IC has shown that a lead compound f...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-06-135
Budget: 09/22/09 - 08/31/10

DESCRIPTION (provided by applicant): Interthyr Corporation (IC) is requesting an Advanced Technology Phase II STTR award to develop a novel agent with a new therapeutic paradigm: Inhibition of Toll-like receptor (TLR) expression and signaling in non-immune cells. In pursuing studies based on its Phase I award, IC has shown that a lead compound f...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 01/31/07

DESCRIPTION (provided by applicant): Toll-like receptors (TLRs) are a family of 11 known cell surface receptors described on immune cells, which initiate proinflammatory signaling pathways in response to pathogen-associated molecular components or environmentally-induced cell damage. Several lines of evidence suggest that overexpression of TLR...